Title of article :
Evaluating the Survival Rate and the Secondary Malignancies after Treating Hodgkinʹs Lymphoma Patients with Chemotherapy Regimens.
Author/Authors :
Ahmadzadeh، Ahmad نويسنده Department of Internal Medicine, Ahwaz Jondishapour University of Medical Sciences, Ahwaz, Iran. Ahmadzadeh, Ahmad , Yekaninejad، Mir Saeed نويسنده Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran , , Jalili، Mohamad H نويسنده Department of internal medicine, school of medicine, Tehran University of medical sciences, Tehran, Iran. Jalili, Mohamad H , Bahadoram، Mohammad نويسنده Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. , , Efazat، Mehdi نويسنده Department of internal medicine, school of medicine, Ahvaz Jundishapur University of Medical Science, Ahvaz, Iran. Efazat, Mehdi , Seghatoleslami، Mohammad نويسنده Health research institute, Research Center of Thalassemia & Hemoglobinopathy,Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Seghatoleslami, Mohammad , Yazdi، Fatemeh نويسنده Department of internal medicine, Ganjavian hospital, Ahvaz Jundishapur University of Medical Science, Ahvaz, Iran. Yazdi, Fatemeh , Mahdipour، Mozhdeh نويسنده Department of surgery, Arvand hospital, Ahvaz Jundishapur University of Medical Science, Ahvaz, Iran. Mahdipour, Mozhdeh , Valizadeh، Armita نويسنده Department of Anatomy, Ahwaz Jondishapour University of Medical Sciences, Ahwaz, Iran. Valizadeh, Armita , Saki، Najmaldin نويسنده Department of Hematology and Blood Banking School of Medical Sciences, Tarbiat Modares University, Tehran, Iran ,
Issue Information :
فصلنامه با شماره پیاپی 0 سال 2014
Pages :
16
From page :
6
To page :
21
Abstract :
In this study we surveyed the average survival time of the treated Hodgkinʹs lymphoma patients and also the side effects and malignancies occurring secondary to the treatment. This is a retrospective study of patients referring to Ahwazʹs Shafa hospital in a period of 10 years diagnosed with Hodgkinʹs lymphoma without any age restriction. After gathering all their data, we calculated their survival rate and the chance for a relapse and the secondary malignancies. 389 patients were included in the study with an average age of 27.5 years old and they had received only chemotherapy regimens. 87.9% of them had been treated by ABVD and 12.1 % by Stanford V regimen. 23.1% of them experienced a relapse and 13.1% of all patients, passed away during the study. Secondary malignancies were observed in 11 cases. An overall mean survival time of 295.31 months was resulted. The secondary malignancies after treating Hodgkinʹs lymphoma patients are different between chemotherapy regimens and chemotherapy - radiotherapy.
Journal title :
International Journal of Hematology-Oncology and Stem Cell Research (IJHOSCR)
Serial Year :
2014
Journal title :
International Journal of Hematology-Oncology and Stem Cell Research (IJHOSCR)
Record number :
2393650
Link To Document :
بازگشت